Company Number: 15035717

Analysis Date: 2025-07-20 14:48 UTC

Financial Health Assessment for ESTE MEDICAL 4 LTD

---

1. Financial Health Score:

Grade: D (Dormant Status; No Financial Activity Recorded)

Explanation:
The company is classified as dormant, meaning it has not engaged in financial transactions during the reported period. As a result, vital financial metrics such as assets, liabilities, revenues, and expenses are all zero. This presents a baseline with no active financial data to evaluate operational health or profitability. While dormancy itself is not inherently negative, prolonged inactivity is akin to a patient in a medically induced coma — stable but not demonstrating vitality or growth.

---

2. Key Vital Signs:

Metric	Value (£)	Interpretation
Current Assets	0	No liquid or short-term resources available.
Current Liabilities	0	No immediate debts or obligations.
Net Current Assets	0	Neutral working capital position.
Total Assets Less Current Liabilities	0	No net asset base to leverage.
Net Assets (Equity)	0	No shareholder equity or retained earnings.
Employees	0	No workforce, indicating no active operations.
Account Status	Dormant	No financial transactions; company inactive.

Additional Context:

• The company was incorporated in July 2023 and has remained dormant through the latest accounting period ending July 2024.
• The company has not filed overdue accounts or confirmation statements, indicating compliance with filing requirements despite inactivity.
• Ownership is concentrated entirely (75-100%) with Mr. Karol Borkowski, who is also the sole director.

---

3. Diagnosis:

The financial "symptoms" indicate that ESTE MEDICAL 4 LTD is in a state of hibernation rather than active business life. With zero financial activity, the company shows no signs of operational stress — no debts, no losses, no revenues — but equally no signs of growth, profitability, or asset accumulation. This is typical for a newly formed entity that has yet to commence trading or has chosen to remain dormant for strategic reasons (e.g., holding a company name, preparing for future operations).

From a financial health perspective, the company is neither ill nor robust; it is effectively in stasis. The absence of financial data means no liquidity risk or solvency concerns presently exist, but there is also no financial momentum or capital build-up. The current state is neutral but requires activation to begin generating business value.

---

4. Recommendations:

• Activate Operations: To transition from dormancy to business vitality, initiate trading activities or other revenue-generating operations. This will provide meaningful financial data and growth opportunities.
• Financial Planning: Develop a clear business plan and cash flow forecast to ensure the company can support operational costs and avoid future liquidity "symptoms" such as cash shortages or mounting liabilities.
• Monitor Compliance: Continue timely filing of accounts and confirmation statements to maintain good standing and avoid regulatory penalties.
• Capital Injection: If planning to grow, consider equity or debt funding to build working capital and fixed assets.
• Regular Financial Reviews: Once active, track key financial metrics regularly (e.g., profitability ratios, liquidity ratios) to diagnose early warning signs of financial distress or inefficiency.
• Engage Advisory Support: Consult financial and business advisors to create a sustainable growth strategy and optimize financial structure.

---